Seite drucken Druckansicht schließen
Logo Going International
Neue Suche | Kongressdetail
 

iPSC-Derived Cell Therapies Summit

Evvnt Promotion / evvnt
Archiv
-
07.12.2021 - 09.12.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Kongressthemen
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies

The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/853667-3?pid=4832

Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/853667-1?pid=4832
Herr Customer Services
 
Kategorien
Allgemeinmedizin, Klinische Forschung
Sprache
Englisch
Kongressgebühr
USD 1899.00 - USD 3597.00
Teilnehmer erwartet
1000
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien